Published in Genes Dev on December 15, 2006
Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci U S A (2009) 4.00
Unleashing formins to remodel the actin and microtubule cytoskeletons. Nat Rev Mol Cell Biol (2009) 3.45
Frequent mutations in the MITF pathway in melanoma. Pigment Cell Melanoma Res (2009) 2.27
Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF. PLoS One (2008) 2.15
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma. Nat Commun (2014) 2.10
Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. Genes Dev (2007) 1.98
Heterogeneous tumor subpopulations cooperate to drive invasion. Cell Rep (2014) 1.88
GLI2-mediated melanoma invasion and metastasis. J Natl Cancer Inst (2010) 1.68
MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells. Proc Natl Acad Sci U S A (2015) 1.68
Cancer stem cells and human malignant melanoma. Pigment Cell Melanoma Res (2008) 1.65
Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination. Cancer Res (2009) 1.63
Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome (PNAS). Genes Dev (2011) 1.52
Gene-disease network analysis reveals functional modules in mendelian, complex and environmental diseases. PLoS One (2011) 1.51
Retracted Formin-like2 regulates Rho/ROCK pathway to promote actin assembly and cell invasion of colorectal cancer. Cancer Sci (2015) 1.46
Chromatin-Remodelling Complex NURF Is Essential for Differentiation of Adult Melanocyte Stem Cells. PLoS Genet (2015) 1.43
SCAI acts as a suppressor of cancer cell invasion through the transcriptional control of beta1-integrin. Nat Cell Biol (2009) 1.42
In melanoma, beta-catenin is a suppressor of invasion. Oncogene (2011) 1.40
Sox proteins in melanocyte development and melanoma. Pigment Cell Melanoma Res (2010) 1.38
MiTF regulates cellular response to reactive oxygen species through transcriptional regulation of APE-1/Ref-1. J Invest Dermatol (2008) 1.23
The Highly Homologous T-Box Transcription Factors, TBX2 and TBX3, Have Distinct Roles in the Oncogenic Process. Genes Cancer (2010) 1.23
A gene expression signature of invasive potential in metastatic melanoma cells. PLoS One (2009) 1.21
Pharmacologic suppression of MITF expression via HDAC inhibitors in the melanocyte lineage. Pigment Cell Melanoma Res (2008) 1.21
miR-148 regulates Mitf in melanoma cells. PLoS One (2010) 1.21
mitfa is required at multiple stages of melanocyte differentiation but not to establish the melanocyte stem cell. Dev Biol (2010) 1.19
Beta-catenin inhibits melanocyte migration but induces melanoma metastasis. Oncogene (2012) 1.18
Novel roles for the MiTF/TFE family of transcription factors in organelle biogenesis, nutrient sensing, and energy homeostasis. Cell Mol Life Sci (2014) 1.14
Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy. Pigment Cell Melanoma Res (2015) 1.12
'Loss of pigment epithelium-derived factor enables migration, invasion and metastatic spread of human melanoma'. Oncogene (2009) 1.12
Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma. Oncogene (2009) 1.09
The dynamic control of signal transduction networks in cancer cells. Nat Rev Cancer (2015) 1.09
Neural Wiskott-Aldrich syndrome protein modulates Wnt signaling and is required for hair follicle cycling in mice. J Clin Invest (2010) 1.08
PGC-1 coactivators regulate MITF and the tanning response. Mol Cell (2012) 1.07
Adaptive stress signaling in targeted cancer therapy resistance. Oncogene (2015) 1.07
Role of microRNA-182 in posterior uveal melanoma: regulation of tumor development through MITF, BCL2 and cyclin D2. PLoS One (2012) 1.07
MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy. Carcinogenesis (2012) 1.06
The roles of microphthalmia-associated transcription factor and pigmentation in melanoma. Arch Biochem Biophys (2014) 1.05
Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway. Oncogene (2011) 1.05
Dynamic remodeling of the actin cytoskeleton by FMNL1γ is required for structural maintenance of the Golgi complex. J Cell Sci (2011) 1.02
Molecular Network Associated with MITF in Skin Melanoma Development and Progression. J Skin Cancer (2011) 1.01
Single-cell gene expression signatures reveal melanoma cell heterogeneity. Oncogene (2014) 1.01
MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment. Nat Commun (2015) 1.01
Microarray analysis sheds light on the dedifferentiating role of agouti signal protein in murine melanocytes via the Mc1r. Proc Natl Acad Sci U S A (2009) 1.00
Phenotype switching in melanoma: implications for progression and therapy. Front Oncol (2015) 1.00
Transcription factor/microRNA axis blocks melanoma invasion program by miR-211 targeting NUAK1. J Invest Dermatol (2013) 0.99
A dual role for SOX10 in the maintenance of the postnatal melanocyte lineage and the differentiation of melanocyte stem cell progenitors. PLoS Genet (2013) 0.99
Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study. Pigment Cell Melanoma Res (2012) 0.98
MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation. Pigment Cell Melanoma Res (2014) 0.97
Chloroquine promotes apoptosis in melanoma cells by inhibiting BH3 domain-mediated PUMA degradation. J Invest Dermatol (2013) 0.97
Differentiated melanocyte cell division occurs in vivo and is promoted by mutations in Mitf. Development (2011) 0.97
MITF in melanoma: mechanisms behind its expression and activity. Cell Mol Life Sci (2014) 0.97
Resistance to transforming growth factor β-mediated tumor suppression in melanoma: are multiple mechanisms in place? Carcinogenesis (2010) 0.97
HOXA1 drives melanoma tumor growth and metastasis and elicits an invasion gene expression signature that prognosticates clinical outcome. Oncogene (2013) 0.96
A phosphatidylinositol 3-kinase-Pax3 axis regulates Brn-2 expression in melanoma. Mol Cell Biol (2012) 0.95
Function of EWS-POU5F1 in sarcomagenesis and tumor cell maintenance. Am J Pathol (2010) 0.94
Loss of pannexin 1 attenuates melanoma progression by reversion to a melanocytic phenotype. J Biol Chem (2012) 0.94
Heterogeneity of expression of epithelial-mesenchymal transition markers in melanocytes and melanoma cell lines. Front Genet (2013) 0.93
The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells. PLoS One (2014) 0.92
PRMT5 is upregulated in malignant and metastatic melanoma and regulates expression of MITF and p27(Kip1.). PLoS One (2013) 0.92
Proteomic signatures of acquired letrozole resistance in breast cancer: suppressed estrogen signaling and increased cell motility and invasiveness. Mol Cell Proteomics (2013) 0.91
Tumor heterogeneity and plasticity as elusive drivers for resistance to MAPK pathway inhibition in melanoma. Oncogene (2014) 0.91
Restricted leucine zipper dimerization and specificity of DNA recognition of the melanocyte master regulator MITF. Genes Dev (2012) 0.91
Pro-survival role of MITF in melanoma. J Invest Dermatol (2014) 0.91
SIRT1 promotes proliferation and inhibits the senescence-like phenotype in human melanoma cells. Oncotarget (2014) 0.90
SOX10 ablation arrests cell cycle, induces senescence, and suppresses melanomagenesis. Cancer Res (2013) 0.90
Dual roles of lineage restricted transcription factors: the case of MITF in melanocytes. Transcription (2012) 0.90
The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma. Arch Biochem Biophys (2014) 0.89
Wnt5A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cells. Pigment Cell Melanoma Res (2014) 0.89
Specification of neural crest into sensory neuron and melanocyte lineages. Dev Biol (2012) 0.88
PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91. Pigment Cell Melanoma Res (2008) 0.88
C-KIT signaling depends on microphthalmia-associated transcription factor for effects on cell proliferation. PLoS One (2011) 0.88
An iterative genetic and dynamical modelling approach identifies novel features of the gene regulatory network underlying melanocyte development. PLoS Genet (2011) 0.88
Melanoma cells revive an embryonic transcriptional network to dictate phenotypic heterogeneity. Front Oncol (2014) 0.88
The role of phenotypic plasticity in the escape of cancer cells from targeted therapy. Biochem Pharmacol (2016) 0.86
CD271 is an imperfect marker for melanoma initiating cells. Oncotarget (2014) 0.86
BRG1 promotes survival of UV-irradiated melanoma cells by cooperating with MITF to activate the melanoma inhibitor of apoptosis gene. Pigment Cell Melanoma Res (2013) 0.86
Pump-probe imaging of pigmented cutaneous melanoma primary lesions gives insight into metastatic potential. Biomed Opt Express (2015) 0.86
Phosphorylation of BRN2 modulates its interaction with the Pax3 promoter to control melanocyte migration and proliferation. Mol Cell Biol (2012) 0.85
The immunohistochemistry of invasive and proliferative phenotype switching in melanoma: a case report. Melanoma Res (2010) 0.85
Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma. Genome Biol (2015) 0.85
Melanoma: from melanocyte to genetic alterations and clinical options. Scientifica (Cairo) (2013) 0.85
In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells. Cell Death Dis (2015) 0.84
MITF and PAX3 Play Distinct Roles in Melanoma Cell Migration; Outline of a "Genetic Switch" Theory Involving MITF and PAX3 in Proliferative and Invasive Phenotypes of Melanoma. Front Oncol (2013) 0.84
Conserved expression signatures between medaka and human pigment cell tumors. PLoS One (2012) 0.84
PAX3 and ETS1 synergistically activate MET expression in melanoma cells. Oncogene (2014) 0.83
Loss of MITF expression during human embryonic stem cell differentiation disrupts retinal pigment epithelium development and optic vesicle cell proliferation. Hum Mol Genet (2014) 0.83
Mitf is a master regulator of the v-ATPase, forming a control module for cellular homeostasis with v-ATPase and TORC1. J Cell Sci (2015) 0.82
A transcriptional network underlies susceptibility to kidney disease progression. EMBO Mol Med (2012) 0.82
Hypoxia-independent drivers of melanoma angiogenesis. Front Oncol (2015) 0.82
Intravital imaging of SRF and Notch signalling identifies a key role for EZH2 in invasive melanoma cells. Oncogene (2014) 0.82
Genetic factors in metastatic progression of cutaneous melanoma: the future role of circulating melanoma cells in prognosis and management. Clin Exp Metastasis (2011) 0.82
Acid sphingomyelinase determines melanoma progression and metastatic behaviour via the microphtalmia-associated transcription factor signalling pathway. Cell Death Differ (2013) 0.82
Microenvironment-derived factors driving metastatic plasticity in melanoma. Nat Commun (2017) 0.81
Insights into the Role of PAX-3 in the Development of Melanocytes and Melanoma. Open Cancer J (2011) 0.81
MITF-independent pro-survival role of BRG1-containing SWI/SNF complex in melanoma cells. PLoS One (2013) 0.81
The transcription factor ATF2 promotes melanoma metastasis by suppressing protein fucosylation. Sci Signal (2015) 0.80
A voting approach to identify a small number of highly predictive genes using multiple classifiers. BMC Bioinformatics (2009) 0.80
Identification of the hypoxia-inducible factor 2α nuclear interactome in melanoma cells reveals master proteins involved in melanoma development. Mol Cell Proteomics (2012) 0.80
MiTF links Erk1/2 kinase and p21 CIP1/WAF1 activation after UVC radiation in normal human melanocytes and melanoma cells. Mol Cancer (2010) 0.80
Microphthalmia-associated transcription factor suppresses invasion by reducing intracellular GTP pools. Oncogene (2016) 0.79
Lunasin is a novel therapeutic agent for targeting melanoma cancer stem cells. Oncotarget (2016) 0.79
Mutations of the BRAF gene in human cancer. Nature (2002) 65.42
Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med (1998) 25.41
BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature (2005) 16.87
Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol (2005) 16.77
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature (2005) 15.28
Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer (2006) 11.22
High frequency of BRAF mutations in nevi. Nat Genet (2002) 9.95
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol (1999) 9.92
A progression puzzle. Nature (2002) 9.56
Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science (1997) 8.99
Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol (2003) 7.93
Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature (1998) 7.76
Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. Nature (1998) 7.30
p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr Biol (1999) 5.40
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature (2001) 4.99
The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat Genet (2005) 4.70
Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell (2006) 4.68
Prespecification and plasticity: shifting mechanisms of cell migration. Curr Opin Cell Biol (2004) 3.78
Melanocytes and the microphthalmia transcription factor network. Annu Rev Genet (2004) 3.78
Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res (2006) 3.42
ROCK and Dia have opposing effects on adherens junctions downstream of Rho. Nat Cell Biol (2002) 3.16
Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche. Science (2004) 3.12
Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin phosphorylation and cell invasion. Nat Cell Biol (2005) 3.02
Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. Cancer Cell (2004) 2.80
Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression. Nature (2005) 2.44
Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship. J Cutan Pathol (2004) 2.43
ROCK and mDia1 antagonize in Rho-dependent Rac activation in Swiss 3T3 fibroblasts. J Cell Biol (2002) 2.05
Beta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor. J Cell Biol (2002) 2.00
Role of RhoA, mDia, and ROCK in cell shape-dependent control of the Skp2-p27kip1 pathway and the G1/S transition. J Biol Chem (2004) 1.98
MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A. J Cell Biol (2004) 1.89
Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res (2005) 1.76
Upstream stimulating factors: highly versatile stress-responsive transcription factors. Pigment Cell Res (2005) 1.71
Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas. Cancer Res (2005) 1.70
Melanocyte development in vivo and in neural crest cell cultures: crucial dependence on the Mitf basic-helix-loop-helix-zipper transcription factor. Development (1997) 1.69
Malignant melanoma: modern black plague and genetic black box. Genes Dev (1998) 1.67
Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation. J Cell Biol (2005) 1.66
The INK4a/ARF tumor suppressor: one gene--two products--two pathways. Trends Biochem Sci (1998) 1.59
Role of keratinocyte-derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes. Pigment Cell Res (2005) 1.54
Role of matrix metalloproteinases in melanoma cell invasion. Biochimie (2005) 1.54
Tbx2 directly represses the expression of the p21(WAF1) cyclin-dependent kinase inhibitor. Cancer Res (2004) 1.44
The transcription network regulating melanocyte development and melanoma. Pigment Cell Res (2004) 1.42
Sumoylation of MITF and its related family members TFE3 and TFEB. J Biol Chem (2004) 1.40
Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study. Am J Pathol (2004) 1.39
The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma. Cancer Res (2002) 1.35
Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner. Pigment Cell Res (2005) 1.28
Protein tyrosine kinases in malignant melanoma. Melanoma Res (2000) 1.18
Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free survival. Am J Pathol (1998) 1.17
The gene encoding the T-box factor Tbx2 is a target for the microphthalmia-associated transcription factor in melanocytes. J Biol Chem (2000) 1.15
Remodeling of the microenvironment by aggressive melanoma tumor cells. Ann N Y Acad Sci (2003) 1.14
MITF and cell proliferation: the role of alternative splice forms. Pigment Cell Res (2005) 1.10
Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment. Cancer Res (2005) 1.06
The cleavage of microphthalmia-associated transcription factor, MITF, by caspases plays an essential role in melanocyte and melanoma cell apoptosis. Genes Dev (2005) 1.02
High levels of expression of p27KIP1 and cyclin E in invasive primary malignant melanomas. J Invest Dermatol (1999) 1.00
Cell proliferation profile of five human uveal melanoma cell lines of different metastatic potential. Pathobiology (2004) 0.97
Rac and rho: the story behind melanocyte dendrite formation. Pigment Cell Res (2002) 0.95
Cytoskeletal mechanisms responsible for invasive migration of neoplastic cells. Int J Dev Biol (2004) 0.91
Diaphanous-related Formin homology proteins. Curr Biol (2002) 0.89
Dynamic regulation of the human dopachrome tautomerase promoter by MITF, ER-alpha and chromatin remodelers during proliferation and senescence of human melanocytes. Pigment Cell Res (2005) 0.87
Melanomas, from the cell cycle point of view (Review). Int J Mol Med (1998) 0.82
NRAS hypermutability in familial melanoma with CDKN2A mutations--cause and effect? J Natl Cancer Inst (2003) 0.79
Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med (2011) 45.46
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med (2011) 26.90
Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell (2011) 6.80
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer. N Engl J Med (2015) 5.39
Oncogenic Braf induces melanocyte senescence and melanoma in mice. Cancer Cell (2009) 4.76
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial. Lancet (2008) 3.62
The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res (2003) 3.58
NUMB controls p53 tumour suppressor activity. Nature (2008) 2.91
Interactions of abiraterone, eplerenone, and prednisolone with wild-type and mutant androgen receptor: a rationale for increasing abiraterone exposure or combining with MDV3100. Cancer Res (2012) 2.81
Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz. Nature (2009) 2.78
Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria. J Clin Oncol (2011) 2.62
Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings. J Clin Oncol (2002) 2.57
Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response. Nature (2007) 2.54
Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study. Lancet Neurol (2009) 2.48
SIVcpz in wild chimpanzees. Science (2002) 2.45
Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells. Oncogene (2004) 2.44
Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression. Nature (2005) 2.44
Cancer stem cells versus phenotype-switching in melanoma. Pigment Cell Melanoma Res (2010) 2.43
Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma. J Clin Oncol (2012) 2.42
P-Rex1 is required for efficient melanoblast migration and melanoma metastasis. Nat Commun (2011) 2.18
Foci of endemic simian immunodeficiency virus infection in wild-living eastern chimpanzees (Pan troglodytes schweinfurthii). J Virol (2003) 2.12
Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial. Lancet Oncol (2012) 2.03
GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus. N Engl J Med (2012) 2.01
The role of BRAF V600 mutation in melanoma. J Transl Med (2012) 2.00
Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. Genes Dev (2007) 1.98
MDM4 is a key therapeutic target in cutaneous melanoma. Nat Med (2012) 1.93
Hypoxia contributes to melanoma heterogeneity by triggering HIF1α-dependent phenotype switching. J Invest Dermatol (2013) 1.91
Aging and fertility patterns in wild chimpanzees provide insights into the evolution of menopause. Curr Biol (2007) 1.89
Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis. Cancer Res (2007) 1.89
Notch signaling via Hes1 transcription factor maintains survival of melanoblasts and melanocyte stem cells. J Cell Biol (2006) 1.86
Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies. Gastroenterology (2013) 1.83
Melanoblasts' proper location and timed differentiation depend on Notch/RBP-J signaling in postnatal hair follicles. J Invest Dermatol (2008) 1.83
FITNESS BENEFITS OF COALITIONARY AGGRESSION IN MALE CHIMPANZEES. Behav Ecol Sociobiol (2012) 1.76
A polymorphism in IRF4 affects human pigmentation through a tyrosinase-dependent MITF/TFAP2A pathway. Cell (2013) 1.75
Dendritic cell sarcoma: an analytic overview of the literature and presentation of original five cases. Crit Rev Oncol Hematol (2007) 1.75
Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up. Blood (2010) 1.74
Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas. Cancer Res (2005) 1.70
Cre-mediated recombination in the skin melanocyte lineage. Genesis (2003) 1.69
EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. Eur J Nucl Med Mol Imaging (2009) 1.68
GLI2-mediated melanoma invasion and metastasis. J Natl Cancer Inst (2010) 1.68
Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma. J Clin Oncol (2013) 1.67
Oncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion. J Invest Dermatol (2012) 1.63
Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort. J Transl Med (2014) 1.59
A purine nucleotide biosynthesis enzyme guanosine monophosphate reductase is a suppressor of melanoma invasion. Cell Rep (2013) 1.58
Development of clinical ethics committees. BMJ (2004) 1.56
The impact of lymphoscintigraphy technique on the outcome of sentinel node biopsy in 1,313 patients with cutaneous melanoma: an Italian Multicentric Study (SOLISM-IMI). J Nucl Med (2006) 1.53
CT-X antigen expression in human breast cancer. Proc Natl Acad Sci U S A (2009) 1.51
Tbx3 represses E-cadherin expression and enhances melanoma invasiveness. Cancer Res (2008) 1.48
Spatiotemporal gene control by the Cre-ERT2 system in melanocytes. Genesis (2006) 1.48
Clinical genetic testing for familial melanoma in Italy: a cooperative study. J Am Acad Dermatol (2009) 1.45
The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer. Nat Cell Biol (2009) 1.44
Tbx2 directly represses the expression of the p21(WAF1) cyclin-dependent kinase inhibitor. Cancer Res (2004) 1.44
The transcription network regulating melanocyte development and melanoma. Pigment Cell Res (2004) 1.42
Genesifter, leading the blind. Pigment Cell Melanoma Res (2007) 1.42
The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity. Proc Natl Acad Sci U S A (2003) 1.41
Survival prediction of stage I lung adenocarcinomas by expression of 10 genes. J Clin Invest (2007) 1.41
Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation. Cancer Res (2008) 1.41
Notch1 and Notch2 receptors influence progressive hair graying in a dose-dependent manner. Dev Dyn (2007) 1.40
Precise nucleosome positioning and the TATA box dictate requirements for the histone H4 tail and the bromodomain factor Bdf1. Mol Cell (2004) 1.39
Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells. Cancer Res (2008) 1.37
Impact of simian immunodeficiency virus infection on chimpanzee population dynamics. PLoS Pathog (2010) 1.34
Wnt5A activates the calpain-mediated cleavage of filamin A. J Invest Dermatol (2009) 1.32
Lineage-specific transcriptional regulation of DICER by MITF in melanocytes. Cell (2010) 1.31
The microphthalmia-associated transcription factor Mitf interacts with beta-catenin to determine target gene expression. Mol Cell Biol (2006) 1.31
Rac1 drives melanoblast organization during mouse development by orchestrating pseudopod- driven motility and cell-cycle progression. Dev Cell (2011) 1.29
The contribution of long-term research at Gombe National Park to chimpanzee conservation. Conserv Biol (2007) 1.29
p38 regulates pigmentation via proteasomal degradation of tyrosinase. J Biol Chem (2010) 1.28
Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991. Eur J Cancer (2011) 1.28
Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP. Cancer Cell (2013) 1.28
Factors associated with the diversification of the gut microbial communities within chimpanzees from Gombe National Park. Proc Natl Acad Sci U S A (2012) 1.27
Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down-regulation of Bcl-2. Apoptosis (2011) 1.26
Small-molecule drugs mimicking DNA damage: a new strategy for sensitizing tumors to radiotherapy. Clin Cancer Res (2009) 1.25
Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo. Oncogene (2005) 1.24
The Brn-2 transcription factor links activated BRAF to melanoma proliferation. Mol Cell Biol (2004) 1.24
Vitamin D and skin cancer: a meta-analysis. Eur J Cancer (2008) 1.22
A new real-time morphology classification for human spermatozoa: a link for fertilization and improved embryo quality. Fertil Steril (2008) 1.21
Amplification of a complete simian immunodeficiency virus genome from fecal RNA of a wild chimpanzee. J Virol (2003) 1.20
Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer. Cancer Immunol Immunother (2003) 1.20
Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy. Cancer Immunol Immunother (2011) 1.19
8p11 myeloproliferative syndrome with a novel t(7;8) translocation leading to fusion of the FGFR1 and TIF1 genes. Genes Chromosomes Cancer (2005) 1.17
An atlas of altered expression of deubiquitinating enzymes in human cancer. PLoS One (2011) 1.17
Heterogeneous nuclear ribonucleoprotein A3, a novel RNA trafficking response element-binding protein. J Biol Chem (2002) 1.15
Directed phenotype switching as an effective antimelanoma strategy. Cancer Cell (2013) 1.15
Systematic classification of melanoma cells by phenotype-specific gene expression mapping. Pigment Cell Melanoma Res (2012) 1.14